Survey on Itch in Outpatients of a University Clinic

NCT03901443 | Completed

• 1 other identifier: UBE 15/114, sp15Mueller3
• Study Type: observational
• Target: 300
• Locations: 1 country
• Sites: 1

Brief Summary

This study is to investigate the pruriception (i.e. the perception of the character and intensity of itch), the impact of itch on quality of life, the response to itch and the subjective efficacy and preferences of the different treatment options among patients with different skin diseases. Better insights into these aspects might help to optimize itch treatment in clinical Settings.

Conditions

Itch

Keywords

itchy skin diseases; itch treatments; pruriception

Outcome Measures

Primary Outcomes (7)

• itch intensity

  Questions regarding itch perception (NRS 0-10; 0 = no itch, 10 = worst imaginable itch) experienced at the moment, within the last 7 days, within the last month

  single time point assessment at baseline

• itch perception

  Questions regarding situations in which the itch is especially bad (multiple choice options regarding day time, daily situations, season); objective assessment in which respondents are asked to select answers from the choices offered as a list

  single time point assessment at baseline

• impact of itch on quality of life

  Questions regarding strength of impact of itch on quality of life (NRS 0-10; 0 = no impact, 10 = extreme)

  single time point assessment at baseline

• quality of sleep

  Questions regarding sleep disturbance by itch (Does itch disturb the patient's sleep and/or sleep of other persons? (yes/no))

  single time point assessment at baseline

• days missing at work

  Approximate number of days missing at work due to itch within last 6 months

  single time point assessment at baseline

• helpfulness of common itch therapies

  Questions regarding helpfulness of common itch therapies (NRS 0-10; 0 = no reduction in itch, 10 = complete reduction of itch; additionally free text options to indicate specific creams, tablets or alternative medicine)

  single time point assessment at baseline

• preferred treatment options

  Questions regarding preferred treatment options (NRS 0- 10; 0 = unimportant, 10 = most important; including additional free text option)

  single time point assessment at baseline

Interventions

Survey on itch OTHER

self-administered patient questionnaire regarding the different aspects of itch

Eligibility Criteria

• Age: 18 Years+
• Sex: all
• Healthy Volunteers: No
• Age Groups: Adult (18-64), Older Adult (65+)
• Sampling Method: Probability Sample

Study Population

All outpatients of the dermatologic university clinic suffering from itch are eligible to participate in the study (from December 2015 until the end of April 2016).

You may qualify if:

• outpatients suffering from itch

You may not qualify if:

• outpatients (suffering from itch) not willing or able to participate

Sponsors & Collaborators

• University Hospital, Basel, Switzerland: lead

Study Sites (1)

Department of Dermatology, University Hospital Basel

Basel, 4031, Switzerland

Location

MeSH Terms

Conditions

Pruritus

Condition Hierarchy (Ancestors)

Skin Diseases; Skin and Connective Tissue Diseases; Skin Manifestations; Signs and Symptoms; Pathological Conditions, Signs and Symptoms

Study Officials

• Simon Müller, Dr. med

  Department of Dermatology, University Hospital Basel

  PRINCIPAL INVESTIGATOR

Study Design

• Study Type: observational
• Observational Model: COHORT
• Time Perspective: CROSS SECTIONAL
• Sponsor Type: OTHER
• Responsible Party: SPONSOR

Study Record Dates

• First Submitted: April 1, 2019
• First Posted: April 3, 2019
• Study Start: December 9, 2015
• Primary Completion: April 30, 2016
• Study Completion: April 30, 2016
• Last Updated: April 8, 2019

Record last verified: 2019-04

Locations

CH (1)